Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Market Cap	14.17B +62.3%
Revenue (ttm)	3.23B +14.4%
Net Income	385.53M +22.3%
EPS	10.14 +15.7%
Shares Out	38.31M
PE Ratio	36.50
Forward PE	n/a
Dividend	5.60 (1.51%)
Ex-Dividend Date	Jun 20, 2025

Volume	180
Average Volume	4,198
Open	369.95
Previous Close	374.00
Day's Range	360.05 - 370.00
52-Week Range	272.40 - 390.00
Beta	n/a
RSI	56.41
Earnings Date	May 5, 2026

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensi...

• Founded: 1976
• Employees: 1,219
• Stock Exchange: Casablanca Stock Exchange
• Ticker Symbol: SOT

Financial Performance

In 2025, CBSE:SOT's revenue was 3.23 billion, an increase of 14.56% compared to the previous year's 2.82 billion. Earnings were 385.53 million, an increase of 22.28%.